Generative AI Solutions Corp. (CSE: AICO, OTCQB: AICOF) is in the middle of a high-stakes accounting shuffle. The company announced that its former auditor, Manning Elliott LLP, resigned effective September 29, 2025, and withdrew its May 2024 audit report on GenAI’s 2024 financial statements. The withdrawal effectively nullifies the previously issued audit, leaving investors without a vetted picture of the company’s finances.
Ataraxis AI, a developer of AI-powered prognostic tools for oncology, has announced a strategic collaboration with MEDSIR, a global leader in oncology research, to integrate artificial intelligence into multiple major international clinical trials. The studies will analyze data from over 1,000 patients, aiming to identify biomarkers that optimize treatment strategies for breast cancer, including CDK4/6 inhibitors and antibody-drug conjugates (ADCs).
Hightouch, a leading data and AI agent platform for marketers, has appointed Akilesh Bapu, co-founder and former CEO of healthcare AI startup Deepscribe, as Head of AI Product Development. Bapu, a Forbes 30 under 30 honoree, brings extensive experience building AI platforms that scale, having led Deepscribe’s growth through multiple funding rounds and partnerships with major health systems.
People.ai, a leading AI data platform, has announced the general availability of its AI-native Forecasting solution, delivering a first-of-its-kind “bottoms-up” approach to pipeline management. The platform gives sales and revenue teams a 360-degree view of deals, offering AI-driven insights into deal risk, progression, closing confidence, and suggested next steps.
Autonomize AI, a pioneer in Agentic AI orchestration for healthcare and life sciences, has announced the appointment of Michele Paige and Tamara Elias, MD to its Growth Advisory Board. They join an experienced roster of leaders, including Joan Harvey, Pritesh Gandhi, MD, MPH, Anthony Nguyen, MD, MBA, and Sarah Bezerredi, shaping the company’s strategy as it scales across health plans, providers, and pharmacy benefit management (PBM) organizations.
Carta, the software platform designed for private capital, has acquired Accelex, an AI-driven data automation platform for alternative investments, in a move aimed at giving institutional Limited Partners (LPs) unprecedented clarity into portfolio performance. The acquisition will power Carta’s new LP Portfolio Analytics suite, enabling LPs to automate document collection, extract KPIs, and accelerate portfolio analysis across multiple data sources.
Route 66, a leading distributor of networking equipment and managed services in Brazil, has formed a strategic partnership with Aprecomm, a provider of AI-driven self-healing network and customer experience solutions. The collaboration will integrate Aprecomm’s award-winning WiFi optimization software and analytics engine into Route 66’s broadband hardware, including gateways and extenders, offering Brazilian service providers an end-to-end solution for improved in-home connectivity.
BigID, a leader in data security, privacy, compliance, and AI governance, has unveiled the industry’s first access control for sensitive data in AI conversations. The platform now offers prompt protection capabilities that prevent sensitive information from being exposed via AI copilots, chatbots, and other AI assistants.
Coupa, the AI-driven leader in Total Spend Management, has rolled out a major platform update packed with over 100 enhancements designed to streamline procurement, finance, and supply chain operations. The release leans heavily on AI-powered automation, building on Coupa’s Navi agent portfolio to bring smarter, faster, and more intuitive workflows for enterprise spend management.
